The Use of EDXRF for Pharmaceutical Material Elemental Analysis
White Paper Apr 24, 2018

The recent changes to the United States Pharmacopeia (USP) regarding requirements for elemental impurity testing has peaked interest into new ways to perform this testing. Combining these new requirements with the introduction of USP chapter <735> X-ray fluorescence spectrometry1 permits a new alternate method for quantifying elemental impurities in pharmaceutical materials.
This study demonstrates that the X-ray Fluorescence (XRF) spectrometry is capable of performing elemental analysis of a wide range of pharmaceutical (liquid, powder and solid) materials with high sensitivity, precision and accuracy for many of the elements required by the United States and the European pharmacopeias. Simple sample preparation, non-destructive analysis, no chemical waste, low running costs with a wide dynamic concentration range and good to excellent detection limits are some of the advantages of this technique.
Related White Papers
Download this compendium to learn more about fragment analyzers and how these are applied to workflows.
READ MOREDownload this case study to learn more about how Thermo Scientific Core LIMS™ and Core ELN™ software solutions are supporting efforts to develop the human microbiome into a new modality for drug development.
READ MORETo gain a further understanding of pipette analysis, view this article on TRACKMAN technology.
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma Cell Science Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE